What one share of Lifecore Biomedical holds
Lifecore Biomedical, Inc. and its subsidiaries (“Lifecore”, the “Company”, “we” or “us”), located in Chaska, Minnesota, is a fully integrated contract development and manufacturing organization (“CDMO”) that offers highly differentiated clinical and commercial capabilities in the development, cGMP manufacturing and aseptic filling of complex formulations and highly viscous sterile injectable pharmaceutical drug or medical device products in syringes, vials and cartridges…
Lifecore Biomedical’s numbers from its SEC filings, divided by its shares. Results cover the latest fiscal year to 2025-05-25; the balance sheet is as of 2026-06-30.
| Sales | $3.70 |
|---|---|
| Profit | −$1.27 |
| Capex (buildings and equipment) | $0.39 |
| Free cash flow | −$0.39 |
| Cash and investments | $0.46 |
| Debt | $4.27 |
| Book value | −$0.90 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2010 | $8.94 | $0.15 | $0.19 | $0.09 | — | — |
| 2011 | $10.39 | $0.15 | $0.25 | $0.29 | — | $5.15 |
| 2012 | $12.15 | $0.49 | $0.21 | $0.64 | — | $5.84 |
| 2013 | $16.59 | $0.85 | $0.33 | $0.46 | — | $6.77 |
| 2014 | $17.58 | $0.71 | $0.55 | $0.23 | — | $7.57 |
| 2015 | $19.73 | $0.50 | $0.64 | $0.33 | — | $8.09 |
| 2016 | $17.63 | −$0.43 | $1.47 | −$0.70 | — | $7.76 |
| 2017 | $16.99 | $0.38 | $0.83 | $0.25 | — | $8.24 |
| 2018 | $18.78 | $0.89 | $1.20 | −$0.49 | — | $9.12 |
| 2019 | $19.49 | $0.01 | $1.56 | −$1.00 | — | $9.28 |
| 2020 | $5.49 | −$1.31 | $0.42 | −$1.00 | — | $7.86 |
| 2021 | $3.44 | −$1.10 | $0.66 | −$0.10 | — | $6.88 |
| 2022 | $3.78 | −$3.96 | $0.89 | −$1.66 | — | $2.98 |
| 2023 | $3.45 | −$3.32 | — | — | — | −$0.14 |
| 2024 | $3.50 | $0.33 | $0.50 | −$0.49 | — | $0.37 |
| 2025 | $3.70 | −$1.27 | $0.39 | −$0.39 | — | $0.04 |
Common questions about Lifecore Biomedical
How much does one share of Lifecore Biomedical earn?
Over its latest fiscal year, Lifecore Biomedical lost $1.27 for each share on $3.70 of sales.
Does Lifecore Biomedical pay a dividend?
Lifecore Biomedical didn’t pay a dividend over its latest fiscal year, according to its SEC filings.
What is Lifecore Biomedical’s book value per share?
Lifecore Biomedical’s book value is negative (−$0.90 per share): it owes more than everything it owns is recorded at, often after years of buying back its own shares, as of June 30, 2026.
How much cash and debt does each share of Lifecore Biomedical have?
Each share of Lifecore Biomedical has $0.46 of cash and investments and $4.27 of debt, as of June 30, 2026.
What is Lifecore Biomedical’s free cash flow per share?
−$0.39 per share over its latest fiscal year. Free cash flow is the cash left over after spending on buildings and equipment.
Has Lifecore Biomedical bought back shares?
Lifecore Biomedical’s share count rose about 31% from 2010 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.